Qilib Hair Regrowth Treatment for Men
Drug Labeling and Warnings
Drug Details [pdf]
QILIB HAIR REGROWTH TREATMENT FOR MEN- minoxidil solution
Galderma Laboratories, L.P.
----------
Qilib Hair Regrowth Treatment for Men
Warnings
Do not use if
you are a woman
your amount of hair loss is different than that shown on the side of this carton or your hair loss is on the front of the scalp. Minoxidil Topical Solution, 5% is not intended for frontal baldness or receding hairline.
you have no family history of hair loss
your hair loss is sudden and/or patchy
you do not know the reason for your hairloss
you are under 18 years of age. Do not use on babies and children
your scalp is red, inflamed, irritated or painful
you use other medicines on the scalp
When using this product
do not apply on other parts of the body
avoid contact wtih the eyes. In cases of accidental contact, rinse eyes with large amounts of cool tap water.
some people have experienced changes in hair color and/or texture.
it takes time to regrow hair. Results may occur at 2 months wtih twice a day usage. For some men, you may need to use this product for at least 4 months before you see results.
the amount of hair regrowth is different for each person. This product will not work for all men.
Stop use and ask a doctor if
side effects occur: You may report side effects to FDA at 1-800-FDA-1088 or to Galderma at 1-866-735-4137.
chest pain, rapid heartbeat, faintness, or dizziness occurs
sudden, unexplained weight gain occurs
your hands or feet swell
scalp irritation or redness occurs
unwanted facial hair growth occurs
you do not see hair regrowth in 4 months
Directions
apply 1 mL with sprayer (6 sprays) 2 times a day directly onto the scalp in the hair loss area
using more or more often will not improve results
continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again
Other information
see hair loss pictures on side of this carton.
before use, read all information on carton and enclosed leaflet.
keep the carton. It contains important information.
hair regrowth has not been shown to last longer than 48 weeks in large clinical trials with continuous treatment with Minoxidil Topical Solution, 5%.
in clinical studies with mostly white men age 18-45 years with moderate degrees of hair loss, Minoxidil Topical Solution, 5% extra strength for men provided more hair regrowth than Minoxidil Topical Solution, 2%.
store at controlled room temperature 20° to 25°C (68° to 77°F). Keep tightly closed.
Package Label
GALDERMA
qilib™
Extra strength
5% MINOXIDIL
TOPICAL SOLUTION
HAIR REGROWTH
TREATMENT
FOR MEN
REACTIVATES HAIR FOLLICLES TO STIMULATE REGROWTH
Clinically proven to help regrow hair
Spray solution for easy application
Unscented
Not for use by women
EASY TO USE
SPRAY BOTTLE
1 month supply
1 - 60mL (2 FL OZ) Bottle
GALDERMA
qilib™
HAIR REGROWTH
TREATMENT
FOR MEN
5% MINOXIDIL TOPICAL SOLUTION
Revitalizes Hair Follicles
(Read enclosed leaflet before use)
Drug Facts
This Package Contains:
One 60 mL (2 FL OZ) Bottle of Qilib Hair Regrowth Treatment For Women (one month supply).
This package also contains an educational booklet.
Qilib Hair Regrowth Treatment For Men (Minoxidil Topical Solution 5%) For men who have a general thinning of hair on the top of the scalp (vertex only as shown below). Not intended for frontal baldness or a receding hairline. 5% Minoxidil Topical Solution has been shown to regrow hair in men with the following degrees of thinning hair or hair loss:
If men have more hair loss or hair loss in a place different than shown above, Qilib Hair Regrowth Treatment For Men may not work.
qilib™
Actual Size of 60 mL (2 FL OZ)
5% MINOXIDIL TOPICAL SOLUTION
Distributed by:
Galderma Laboratories, LP.
Fort Worth, Texas 76177 USA
All trademarks are the property of thier respective owners
P52977-0
| QILIB HAIR REGROWTH TREATMENT FOR MEN
minoxidil solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
| Labeler - Galderma Laboratories, L.P. (047350186) |